These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported Terminated 2006-003656-38 A Double-blind, Randomised, Parallel Groups Investigation into the Effects of Pregabalin, Duloxetine and Amitriptyline on Aspects of Pain, Sleep, and Next Day Performance in Patients Suffering from Di... 2009-05-12 due-trials
Completed, but no date Terminated 2006-006424-18 THE EFFECT OF RIMONABANT ON ENERGY EXPENDITURE, FATTY ACID METABOLISM, TRIACYLGLYCEROL METABOLISM AND BODY FAT DISTRIBUTION bad-data
Ongoing 2007-003085-17 The effect of insulin detemir on energy balance, postprandial nutrient handling, body fat distribution,and adipose tissue metabolism and gene expression in patients with type 2 diabetes. not-yet-due
Ongoing 2008-005363-34 Investigation to explore whether there is a synergistic effect between nicotine replacement therapy and guided bodyscanning on cigarette cravings and withdrawal symptoms in temporarily abstinent smoke... not-yet-due
Not reported 2009-017806-36 Effect of Vitano® on physiological and psychological responses to psychological stress assessed under laboratory conditions and in everyday life. 2011-07-26 due-trials
Ongoing 2011-001642-14 The effects of subcutaneous insulin detemir on glucose flux, pharmacokinetics and brain function in type one diabetes not-yet-due
Ongoing, reported early 2013-002826-22 The effect of Lixisenatide on triacylglycerol and glucose metabolism in patients with type 2 diabetes not-yet-due
Ongoing 2014-002708-26 A randomised double blind placebo controlled pilot trial of oxytocin efficacy in treating detoxified opioid dependent individuals not-yet-due
Ongoing 2015-002094-38 The Effect of an SGLT2 inhibitor on Glucose Flux, Lipolysis and Ketogenesis following insulin withdrawal in People with absolute or relative endogenous insulin deficiency not-yet-due